These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2905786)

  • 1. Modulation of morphine-induced EEG and behavioral effects by dynorphin A-(1-13) in non-tolerant and morphine-tolerant rats.
    Hong O; Young GA; Khazan N
    Neuropharmacology; 1988 Aug; 27(8):807-12. PubMed ID: 2905786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between regulation of morphine-induced EEG effects and changes in naloxone sensitivity.
    Paquette NC; Young GA
    Eur J Pharmacol; 1991 Apr; 196(1):61-7. PubMed ID: 1678713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynorphin A-(1-13)-morphine interactions: quantitative and qualitative EEG properties differ in morphine-naive vs. morphine-tolerant rats.
    Meng Y; Young GA
    Brain Res Bull; 1994; 33(3):255-65. PubMed ID: 7904888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential tolerance and cross-tolerance to repeated daily injections of mu and kappa opioid agonists in the rat.
    Young GA; Khazan N
    Neuropharmacology; 1984 May; 23(5):505-9. PubMed ID: 6330605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naltrindole retards tolerance development to morphine-induced effects on EEG and EEG power spectra.
    Stamidis H; Young GA
    Eur J Pharmacol; 1992 Mar; 213(1):9-16. PubMed ID: 1499659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mu-delta opioid interactions. II: Beta-FNA inhibits DPDPE-induced increases in morphine EEG and EEG spectral power.
    Stamidis H; Young GA
    Peptides; 1992; 13(4):755-60. PubMed ID: 1331999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecally administered dynorphin-(1-17) modulates morphine-induced antinociception differently in morphine-naive and morphine-tolerant rats.
    Schmauss C; Herz A
    Eur J Pharmacol; 1987 Mar; 135(3):429-31. PubMed ID: 2884124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-administration of dynorphin-[1-13] and D-ala2-dynorphin-[1-11] (kappa opioid agonists) in morphine (mu opioid agonist)-dependent rats.
    Khazan N; Young GA; Calligaro D
    Life Sci; 1983; 33 Suppl 1():559-62. PubMed ID: 6319910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynorphin-(1-13): antinociceptive action and its effects on morphine analgesia and acute tolerance.
    Kishioka S; Morita N; Kitabata Y; Yamanishi T; Miyamoto Y; Ozaki M; Yamamoto H
    Jpn J Pharmacol; 1992 Nov; 60(3):197-207. PubMed ID: 1362787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of acute morphine tolerance by corticotropin-releasing factor and dynorphin A in the mouse spinal cord.
    Song SH; Takemori AE
    Life Sci; 1992; 51(2):107-11. PubMed ID: 1352026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential tolerance to repeated daily injections of N-allylnormetazocine and its enantiomers in the rat.
    Young GA; Hong O; Khazan N
    Neuropharmacology; 1987 May; 26(5):463-7. PubMed ID: 3037416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholecystokinin octapeptide alters morphine-induced effects on EEG power spectra both quantitatively and qualitatively.
    Hudson GM; Marquis KL; Stamidis H; Young GA
    Eur J Pharmacol; 1992 Oct; 221(2-3):217-22. PubMed ID: 1426001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electroencephalographic and behavioral effects of D-ala2-methionine-enkephalinamide and morphine in the rat.
    Tortella FC; Moreton JE; Khazan N
    J Pharmacol Exp Ther; 1978 Sep; 206(3):636-43. PubMed ID: 702326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid receptor agonists selective for mu and kappa receptors attenuate methamphetamine-induced behavioral sensitization in the mouse.
    Toyoshi T; Ukai M; Kameyama T
    Biol Pharm Bull; 1996 Mar; 19(3):369-74. PubMed ID: 8924903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects of dynorphin A (1-13) in conscious rats and its modulation of morphine bradycardia over time.
    Glatt CE; Kenner JR; Long JB; Holaday JW
    Peptides; 1987; 8(6):1089-92. PubMed ID: 2894646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mu-delta opioid interactions. I: The delta peptide, DPDPE, increases morphine-induced EEG and EEG spectral power.
    Stamidis H; Young GA
    Peptides; 1992; 13(4):749-53. PubMed ID: 1331998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [D-Pro10]-dynorphin(1-11) is a kappa-selective opioid analgesic in mice.
    Gairin JE; Gout R; Meunier JC; Cros J
    J Pharmacol Exp Ther; 1988 Jun; 245(3):995-1001. PubMed ID: 2898527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic profiles of morphine-induced EEG, EEG power spectra, and behavior in two inbred rat strains.
    Mayo-Michelson L; Young GA
    Brain Res Bull; 1993; 30(1-2):79-84. PubMed ID: 8420638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analgesic effects of dynorphin-A and morphine in mice.
    Nakazawa T; Ikeda M; Kaneko T; Yamatsu K
    Peptides; 1985; 6(1):75-8. PubMed ID: 2859574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphine-like effects of clonidine on the EEG, slow wave sleep and behavior in the dog.
    Pickworth WB; Sharpe LG; Gupta VN
    Eur J Pharmacol; 1982 Jul; 81(4):551-7. PubMed ID: 7117387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.